- Published at
- by raskmedia.com.au
mixed
mixed
News for CSL Limited (CSLN.MX)
- Published at
- by gurufocus.com
positivepositiveEsperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia
”“ Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales ”“ ANN ARBOR, Mich., March 03, 2- Published at
- by forbes.com
neutralneutralInside Takeda’s Plasma-Derived Therapy Ecosystem
Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, a key revenue driver at $5.85B in 2023.- Published at
- by under30ceo.com
positivepositiveBuffett backs CSL, Life360, WiseTech in latest move
Billionaire investor Warren Buffett's firm invests in Australian companies CSL, Life360, and WiseTech in a strategic financial move.- Published at
- by seekingalpha.com
neutralneutralCSL Limited 2025 Q2 - Results - Earnings Call Presentation (OTCMKTS:CSLLY)
The following slide deck was published by CSL Limited in conjunction with their 2025 Q2 earnings call.- Published at
- by seekingalpha.com
positivepositiveCSL Limited (CSLLY) Q2 2025 Earnings Call Transcript
CSL Limited (OTCQX:CSLLY) Q2 2025 Results Earnings Conference Call February 10, 2025 7:00 PM ETCompany ParticipantsChris Cooper - Vice President and Head of...- Published at
- by themarketherald.com.au
positivepositiveCSL up 6% on strong demand for CSL Behring business
CSL Ltd has reported rises in profit and revenue for the first half of the 2025 fiscal year, with particular growth in its CSL Behring arm- Published at
- by manilatimes.net
neutralneutralFormer CSL CEO Paul Perreault appointed strategic adviser to Microbio
Establishing sepsis diagnostic InfectID™ as the new standard of care- Published at
- by themarketherald.com.au
neutralneutralWeek 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL
Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.- Published at
- by globenewswire.com
mixedmixedNeedle-Free Injector Market Will Reach USD 43.4 Billion By 2032, Driven by The Growing Demand for Needle-Free Drug Delivery Solutions
The Needle-Free Injector Market is growing rapidly along with the escalating requirements of pain-free drug delivery systems, greater needle-phobic...- Published at
- by globenewswire.com
mixedmixedGlobal Vaccine Market Size Expected to Reach USD 186.5 Billion by 2032 with 10.7% CAGR - SNS Insider
According to Research by SNS Insider, Vaccine Market Growth is Driven by Increasing Government Support, Technological Innovations, and Growing Demand for...- Published at
- by benzinga.com
mixedmixedWall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Gilead Sciences (NASDAQ:GILD)
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash f...- Published at
- by medium.com
mixedmixedImmune Thrombocytopenia Market: Novel Therapies Targeting Platelet Disorders
As per Fortune Business Insights’ report, the immune thrombocytopenia Market share sector attained a worth of USD 2.99 Billion in 2018. Forecasts indicate a promising path, foreseeing a Compound…- Published at
- by investing.com
positivepositiveArcturus shares gain as William Blair affirms Outperform rating By Investing.com
Arcturus shares gain as William Blair affirms Outperform rating- Published at
- by medium.com
mixedmixedImmunoglobulins Market: Key Trends Driving the Immunoglobulins Market Forward
As per Fortune Business Insights’ report, the immunoglobulins Market share sector attained a worth of USD 16.24 Billion in 2023. Forecasts indicate a promising path, foreseeing a Compound Annual…- Published at
- by seekingalpha.com
positivepositiveCSL Limited: Good Results Overshadowed By Below-Expectations Guidance (OTCMKTS:CMXHF)
CSL Limited's FY 2024 results were strong, but FY 2025 guidance fell short due to expected underperformance in certain segments. Read why CMXHF stock is a Hold.- Published at
- by seekingalpha.com
positivepositiveCSL Limited (CSLLY) Q4 2024 Earnings Call Transcript
CSL Limited (OTCQX:CSLLY) Q4 2024 Results Conference Call August 12, 2024 9:00 PM ETCompany ParticipantsJoy Linton - CFOChris Cooper - Head, IRPaul McKenzie...- Published at
- by medium.com
mixedmixedIdiopathic Inflammatory Myopathy Treatment Market Expansion Fueled by Advancements in Autoimmune Disease Treatments
As per Fortune Business Insights’ report, the idiopathic inflammatory myopathy treatment Market share sector attained a worth of USD 652.3 million in 2018. Forecasts indicate a promising path ahead…- Published at
- by raskmedia.com.au
mixedmixedThe blackhole inside Commonwealth Bank of Australia (ASX:CBA) shares
The Commonwealth Bank of Australia (ASX: CBA) share price might be up 55% over 10 years. But how fast have CBA's profits grown in that time?- Published at
- by seekingalpha.com
mixedmixedEWA: The Case For Australia Grows (NYSEARCA:EWA)
iShares MSCI Australia ETF is a low-cost option for targeted exposure to Australian equities with a focus on large and mid-cap companies. Learn more on EWA ETF here.